Prioritizing clinical trials tech: How 16 tech-driven markets stack up across maturity and momentum
This report uses the CB Insights TECH Framework to rank clinical trials markets based on current commercial readiness and momentum.
This report uses the CB Insights TECH Framework to rank clinical trials markets based on current commercial readiness and momentum.
We map the startups in the AI agents space based on their Commercial Maturity scores.
We mined Morgan Stanley’s acquisitions and partnerships to discern the company’s strategic priorities in wealth management.
We surveyed 50 strategy team leaders to identify their key challenges — and the tactics they use to overcome them. Here’s what the most successful teams are doing to influence their organizations.
We break down the current payments landscape across funding trends, M&A, and more.
From rapid, on-site diagnostics to novel stem cell therapies, animal health is seeing a wave of innovations to prevent, diagnose, and treat disease.
OpenAI co-founder Ilya Sutskever’s AI startup Safe Superintelligence (SSI) recently raised $1B, but it’s only the latest in an unprecedented run of billion-dollar AI funding rounds.
We look at how 4 tech giants are pursuing their sustainability goals through strategic investments, partnerships, and other initiatives.